Silence Therapeutics plc
SLN
$5.35
-$0.11-2.02%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.35M | -28.53M | 10.34M | -35.15M | -19.76M |
| Total Depreciation and Amortization | 148.00K | 138.00K | 149.80K | 149.70K | 150.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.92M | 5.59M | -11.36M | 8.78M | 3.26M |
| Change in Net Operating Assets | -4.50M | 10.49M | -26.76M | 638.90K | 10.93M |
| Cash from Operations | -21.78M | -12.31M | -27.62M | -25.58M | -5.41M |
| Capital Expenditure | -48.00K | -4.00K | -65.80K | -63.80K | -85.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.51M | -44.38M | 62.39M | -37.47M | 42.00K |
| Cash from Investing | -1.56M | -44.38M | 62.32M | -37.53M | -43.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 182.80K | -49.00K | -- |
| Issuance of Common Stock | 1.00K | 14.00K | -- | 6.34M | 1.19M |
| Repurchase of Common Stock | -- | -- | -7.38M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 8.60M | -322.00K | -- |
| Cash from Financing | 1.00K | 14.00K | 1.40M | 7.77M | 1.19M |
| Foreign Exchange rate Adjustments | 198.00K | 232.00K | 6.53M | -6.51M | -14.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.15M | -56.44M | 42.62M | -61.85M | -4.27M |